newsfilter
← Latest News
PR Newswire·

Leap Therapeutics to Participate at Upcoming Investor Conferences

CAMBRIDGE, Mass., Sept. 5, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi,